Literature DB >> 15158471

Improved and automated prediction of effective siRNA.

Alistair M Chalk1, Claes Wahlestedt, Erik L L Sonnhammer.   

Abstract

Short interfering RNAs are used in functional genomics studies to knockdown a single gene in a reversible manner. The results of siRNA experiments are highly dependent on the choice of siRNA sequence. In order to evaluate siRNA design rules, we collected a database of 398 siRNAs of known efficacy from 92 genes. We used this database to evaluate previously proposed rules from smaller datasets, and to find a new set of rules that are optimal for the entire database. We also trained a regression tree with full cross-validation. It was however difficult to obtain the same precision as methods previously tested on small datasets from one or two genes. We show that those methods are overfitting as they work poorly on independent validation datasets from multiple genes. Our new design rules can predict siRNAs with efficacy >/= 50% in 91% of cases, and with efficacy >/=90% in 52% of cases, which is more than a twofold improvement over random selection. Software for designing siRNAs is available online via a web server at or as a standalone version for high-throughput applications.

Mesh:

Substances:

Year:  2004        PMID: 15158471     DOI: 10.1016/j.bbrc.2004.04.181

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  39 in total

1.  Development of novel cell lines of diabetic dysfunction model fit for cell-based screening tests of medicinal materials.

Authors:  Mikako Saito; Aya Hayakawa; Nobuya Inagaki; Hideaki Matsuoka
Journal:  Cytotechnology       Date:  2012-07-10       Impact factor: 2.058

Review 2.  Toward a complete in silico, multi-layered embryonic stem cell regulatory network.

Authors:  Huilei Xu; Christoph Schaniel; Ihor R Lemischka; Avi Ma'ayan
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010 Nov-Dec

3.  Effect of vector-expressed shRNAs on hTERT expression.

Authors:  Ying Guo; Jun Liu; Ying-Hui Li; Tian-Bao Song; Jing Wu; Cai-Xia Zheng; Cai-Fang Xue
Journal:  World J Gastroenterol       Date:  2005-05-21       Impact factor: 5.742

4.  Sequence characteristics of functional siRNAs.

Authors:  Bernd Jagla; Nathalie Aulner; Peter D Kelly; Da Song; Allen Volchuk; Andrzej Zatorski; David Shum; Thomas Mayer; Dino A De Angelis; Ouathek Ouerfelli; Urs Rutishauser; James E Rothman
Journal:  RNA       Date:  2005-06       Impact factor: 4.942

Review 5.  Preclinical and clinical development of siRNA-based therapeutics.

Authors:  Gulnihal Ozcan; Bulent Ozpolat; Robert L Coleman; Anil K Sood; Gabriel Lopez-Berestein
Journal:  Adv Drug Deliv Rev       Date:  2015-02-07       Impact factor: 15.470

Review 6.  Lentiviral vector-mediated RNA silencing in the central nervous system.

Authors:  Thomas H Hutson; Edmund Foster; Lawrence D F Moon; Rafael J Yáñez-Muñoz
Journal:  Hum Gene Ther Methods       Date:  2013-11-01       Impact factor: 2.396

7.  Long-range transcriptome sequencing reveals cancer cell growth regulatory chimeric mRNA.

Authors:  Roberto Plebani; Gavin R Oliver; Marco Trerotola; Emanuela Guerra; Pamela Cantanelli; Luana Apicella; Andrew Emerson; Alessandro Albiero; Paul D Harkin; Richard D Kennedy; Saverio Alberti
Journal:  Neoplasia       Date:  2012-11       Impact factor: 5.715

8.  siRecords: a database of mammalian RNAi experiments and efficacies.

Authors:  Yongliang Ren; Wuming Gong; Haiyan Zhou; Yejun Wang; Feifei Xiao; Tongbin Li
Journal:  Nucleic Acids Res       Date:  2008-11-07       Impact factor: 16.971

9.  Asymmetrically designed siRNAs and shRNAs enhance the strand specificity and efficacy in RNAi.

Authors:  Hongliu Ding; Guoqing Liao; Hongyan Wang; Yejin Zhou
Journal:  J RNAi Gene Silencing       Date:  2007-08-15

10.  siDirect 2.0: updated software for designing functional siRNA with reduced seed-dependent off-target effect.

Authors:  Yuki Naito; Jun Yoshimura; Shinichi Morishita; Kumiko Ui-Tei
Journal:  BMC Bioinformatics       Date:  2009-11-30       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.